Genetic architecture of lipid traits changes over time and differs by race: Princeton Lipid Follow-up Study
- PMID: 24859784
- PMCID: PMC4076086
- DOI: 10.1194/jlr.M049932
Genetic architecture of lipid traits changes over time and differs by race: Princeton Lipid Follow-up Study
Abstract
Dyslipidemia is a major risk factor for CVD. Previous studies on lipid heritability have largely focused on white populations assessed after the obesity epidemic. Given secular trends and racial differences in lipid levels, this study explored whether lipid heritability is consistent across time and between races. African American and white nuclear families had fasting lipids measured in the 1970s and 22-30 years later. Heritability was estimated, and bivariate analyses between visits were conducted by race using variance components analysis. A total of 1,454 individuals (age 14.1/40.6 for offspring/parents at baseline; 39.6/66.5 at follow-up) in 373 families (286 white, 87 African American) were included. Lipid trait heritabilities were typically stronger during the 1970s than the 2000s. At baseline, additive genetic variation for LDL was significantly lower in African Americans than whites (P = 0.015). Shared genetic contribution to lipid variability over time was significant in both whites (all P < 0.0001) and African Americans (P ≤ 0.05 for total, LDL, and HDL cholesterol). African American families demonstrated shared environmental contributions to lipid variation over time (all P ≤ 0.05). Lower heritability, lower LDL genetic variance, and durable environmental effects across the obesity epidemic in African American families suggest race-specific approaches are needed to clarify the genetic etiology of lipids.
Keywords: epidemiology; family study; genetics; high density lipoprotein; longitudinal; low density lipoprotein; triglycerides.
Copyright © 2014 by the American Society for Biochemistry and Molecular Biology, Inc.
Figures
References
-
- Roger V. L., Go A. S., Lloyd-Jones D. M., Benjamin E. J., Berry J. D., Borden W. B., Bravata D. M., Dai S., Ford E. S., Fox C. S., et al. 2012. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 125: e2–e220 [Erratum. 2012. Circulation 125: e1002.] - PMC - PubMed
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285: 2486–2497 - PubMed
-
- Lloyd-Jones D. M., Hong Y., Labarthe D., Mozaffarian D., Appel L. J., Van Horn L., Greenlund K., Daniels S., Nichol G., Tomaselli G. F., et al. 2010. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond. Circulation. 121: 586–613 - PubMed
-
- Prins B. P., Lagou V., Asselbergs F. W., Snieder H., Fu J. 2012. Genetics of coronary artery disease: genome-wide association studies and beyond. Atherosclerosis. 225: 1–10 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
